<DOC>
	<DOCNO>NCT01686828</DOCNO>
	<brief_summary>The purpose research study understand effect testosterone estrogen body 's response hormone insulin .</brief_summary>
	<brief_title>T-IR- Study Understand Effects Testosterone Estrogen Body 's Response Hormone Insulin</brief_title>
	<detailed_description>The investigator examine effect testosterone insulin sensitivity body composition men . This study may lend great insight increase risk diabetes evident men low circulating level testosterone . Three drug use study : acyline , give injection ; testosterone ( T ) gel apply skin ; letrozole , oral drug block conversion androgen ( male hormone ) estrogen ( female hormone ) . Acyline inhibits production luteinizing hormone ( LH ) follicle stimulate hormone ( FSH ) . When acyline stop production hormone , block signal brain stimulates testicle make testosterone . Adding testosterone acyline restore physiologic level testosterone study participant . One group men receive T gel letrozole , aromatase inhibitor ; men normal level testosterone low level estrogen blood . This design enable determination respective metabolic effect testosterone estrogen .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>PSA ≤ 3 ng/mL Age 2555 year Ability understand study , study procedure provide inform consent Serum total T &gt; 300 ng/dL Normal reproductive history exam International Prostate Symptom Score ( IPSS ) &lt; 11 A history prostate cancer include suspicious DRE history highgrade PIN prostate biopsy Invasive therapy BPH past History acute urinary retention previous 3 month Current recent past use androgenic antiandrogenic drug , steroid drug interfere steroid metabolism ( within last 3 month ) Current use statin glucocorticoid Severe systemic illness ( renal , liver , cardiac , lung disease , cancer , diabetes mellitus ) skin disease A history current breast cancer Known , untreated obstructive sleep apnea Hematocrit &gt; 50 &lt; 34 Hypersensitivity drug use study History bleed disorder anticoagulation Participation drug study within past 90 day History drug alcohol abuse within last 12 month Weight &gt; 280 lb . BMI ≥ 33 Desire fertility next 6 month current pregnant partner Sperm concentration &lt; 14 million/ml Significant , uncontrolled hypertension ( BP &gt; 160/100 mmHg ) ; subject wellcontrolled BP medical therapy eligible participate</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>insulin</keyword>
	<keyword>androgen</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>testosterone</keyword>
	<keyword>estradiol</keyword>
	<keyword>obesity</keyword>
</DOC>